web analytics

Latest News

Welcome to Discuva

Discuva is a drug discovery company focused on the creation of Next Generation targeted antimicrobials against new emerging and drug-resistant bacterial pathogens.

From a study of 114 countries, the World Health Organisation has predicted a future where all current antibiotic drugs are ineffective. In this ‘post-antibiotic era’ a simple scratch or routine surgical procedure will be a potentially life-threatening event.

At Discuva, using ground-breaking new technologies, we are successfully developing completely new classes of antibiotics which we believe will play a major role in protecting society from the forthcoming threat promised by the emergence of drug-resistant bacteria.

Upcoming Events

Latest Tweets from @DiscuvaLtd

Discuva Ltd @DiscuvaLtd
#Superbugs: How Antibiotic-Resistant Bugs Are Killing Mankind https://t.co/DoYv98rt5k
Discuva Ltd @DiscuvaLtd
RT @NatureMedicine: Studying the "resistome" and "mobilome" offer clues to combat #antibioticresistance. More: https://t.co/bez5dsAN35 http…
Discuva Ltd @DiscuvaLtd
5 Ways a Post-Antibiotic Era Could Change Medicine https://t.co/RUr3WJJUg7